by Gregory J Leyer, PhD, et al.
July 30, 2009
Objective: Probiotic consumption effects on cold and influenza-like symptom incidence and duration were evaluated in healthy children during the winter season.
Methods: In this double-blind, placebo-controlled study, 326 eligible children (3 to 5 years of age) were assigned randomly to receive placebo (N = 104), Lactobacillus acidophilus NCFM (N = 110), or L acidophilus NCFM in combination with Bifidobacterium animalis subsp lactis Bi-07 (N = 112). Children were treated twice daily for 6 months.
Results:
• Relative to the placebo group, single and combination probiotics reduced fever incidence by 53.0% (P = .0085) and 72.7% (P = .0009), coughing incidence by 41.4% (P = .027) and 62.1% (P = .005), and rhinorrhea [runny nose] incidence by 28.2% (P = .68) and 58.8% (P = .03), respectively.
• Fever, coughing, and rhinorrhea duration was decreased significantly, relative to placebo, by 32% (single strain; P = .0023) and 48% (strain combination; P < .001).
• Antibiotic use incidence was reduced, relative to placebo, by 68.4% (single strain; P = .0002) and 84.2% (strain combination; P < .0001).
• Subjects receiving probiotic products had significant reductions in days absent from group child care, by 31.8% (single strain; P = .002) and 27.7% (strain combination; P < .001), compared with subjects receiving placebo treatment.
Conclusion: Daily dietary probiotic supplementation for 6 months was a safe effective way to reduce fever, rhinorrhea, and cough incidence and duration and antibiotic prescription incidence, as well as the number of missed school days attributable to illness, for children 3 to 5 years of age.
Source: Pediatrics, Aug 2009; 124(2)172-179. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Department of Research and Development, Danisco, Madison, Wisconsin; Department of Preventive Medicine, Medical College of Tongji University, Shanghai, China; Department of Biostatistics, School of Public Health, University of Texas at Houston, Dallas Regional Campus; Department of Scientific Affairs, SPRIM USA, Frisco, Texas; Department of Research and Development, Danisco, Kantvik, Finland.
|
